St. Louis scientists say they’ve determined how HIV invades healthy cells – and that could lead to improved drug therapies to fight the deadly disease. The researchers at the Saint Louis University Institute for Molecular Virology demonstrated the molecular mechanism by which the HIV virus infects, or integrates, healthy cells.
IBM announced that the virtual supercomputer will test thousands of human immuno-deficiency virus (HIV) mutations against tens of thousands of chemical compounds.
Experiments in female monkeys have for the first time shown that when used in combination, vaginal gels known as microbicides can protect against an HIV-like virus. The research, funded largely by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), suggests that similar combination microbicides could potentially provide a safe, effective and practical way to prevent HIV transmission to women, according to study investigators.
The Food and Drug Administration (FDA) announced the tentative approval of the drug product Lamivudine (la mi’ vyoo deen) Oral Solution, 10 mg/mL manufactured by Aurobindo Pharma LTD. of Hyderabad , India . Lamivudine Oral Solution is the first generic version of the already approved Epivir Oral Solution, 10 mg/mL, manufactured by GlaxoSmithKline. This child-friendly-product is indicated for use in pediatric patients with HIV from three months to 16 years, and will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.
Authorities in the U.S. are considering the approval of the first rapid home testing kit for HIV.
These three words echo around the world . . . AIDS CRISIS WORSENS! – 40 million people infected worldwide – 37.2 million adults – 2.2 million children under 15.
The only way to know if one is infected is to be tested for HIV infection. You cannot rely on symptoms to know whether or not you are infected. Many people who are infected with HIV do not have any symptoms at all for many years.
FDA announced the tentative approval of zidovudine oral solution, a generic version of a child-friendly oral solution to help keep AIDS virus from reproducing.
Early research by scientists in the U.S. suggests that valproic acid could be a potential way to eradicate dormant HIV infections.
New research published in the August 2005 issue of the American Journal of Psychiatry indicates that methamphetamine abuse and HIV infection cause significant alterations in the size of certain brain structures, and in both cases the changes may be associated with impaired cognitive functions, such as difficulties in learning new information, solving problems, maintaining attention and quickly processing information.